Treace Medical Concepts, Inc.

Historical 13F Holders

Symbol
TMCI
CUSIP
89455T109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 89455T109 since 12/18/2024, largest first.

Filer % of Class Filed
John T. Treace 13G/A 19.2% 8/12/2026
Event 6/30/2026
Armistice Capital, LLC 13G/A
9.8% 8/14/2026
Event 6/30/2026
Gagnon Securities LLC 13G/A
9.6% 2/12/2026
Event 12/31/2025
Bank of America Corp /DE/ 13G 5.5% 5/14/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Morgan Stanley 13G/A 3.4% 2/3/2025
Event 12/31/2024
William Blair Investment Management, LLC 13G/A 1.8% 2/9/2026
Event 12/31/2025
BlackRock, Inc. 13G/A 1.5% 7/30/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 8.50 k $37.7 k
2026 Q2 120 31.9 M $127 M
2026 Q1 119 36.0 M $48.3 M
2025 Q4 121 35.9 M $88.0 M
2025 Q3 121 40.4 M $271 M
2025 Q2 128 39.3 M $231 M
2025 Q1 143 38.0 M $315 M
2024 Q4 141 37.5 M $279 M
2024 Q3 143 41.0 M $237 M
2024 Q2 137 43.0 M $286 M
2024 Q1 140 48.3 M $629 M
2023 Q4 136 44.9 M $572 M
2023 Q3 131 39.2 M $514 M
2023 Q2 144 40.7 M $1.04 B
2023 Q1 136 37.2 M $938 M
2022 Q4 115 29.7 M $648 M
2022 Q3 98 26.8 M $591 M
2022 Q2 89 23.1 M $332 M
2022 Q1 82 20.4 M $386 M
2021 Q4 81 30.2 M $449 M
2021 Q3 63 13.0 M $351 M
2021 Q2 73 14.2 M $445 M
2021 Q1 1 179 $6.00 k
2020 Q4 1 179 $6.00 k
2020 Q3 1 179 $6.00 k
2020 Q2 1 179 $6.00 k
2020 Q1 1 179 $6.00 k
2019 Q4 1 179 $6.00 k
2019 Q3 1 179 $6.00 k
2019 Q2 1 179 $6.00 k
2019 Q1 1 179 $6.00 k